5 unchanged sentences
Number Description of Exhibit Form Filing Date Number
+Added: Agreement and Plan of Merger, dated October 27, 2020, by and among the Registrant, Oculus Merger Sub I, Inc., Oculus Merger Sub II, LLC and Viridian Therapeutics, Inc.
+Added: 8-K 10/28/2020 2.1
Certificate of Incorporation of the Registrant.
12 unchanged sentences
8-K 02/13/2017 3.4
+Added: Certificate of Designation of Series A Non-Voting Convertible Preferred Stock.
+Added: 8-K 10/28/2020 3.1
Specimen Common Stock Certificate.
2 unchanged sentences
8-K 02/07/2020 4.1
−Removed: Fourth Addendum to Lease by and between Registrant and Crestview, LLC, dated as of April 7, 2020.
−Removed: 10-Q 05/08/2020 10.2
−Removed: Amendment to Research Subaward Agreement, entered into as of April 7, 2020, by and between Registrant and Yale University.
−Removed: 10-Q 05/08/2020 10.3
−Removed: Deferral Agreement between Silicon Valley Bank and the Registrant effective as of April 6, 2020.
−Removed: 10-Q 05/08/2020 10.4
−Removed: Small Business Administration Paycheck Protection Program Note, by and between the Registrant and Silicon Valley Bank, dated April 21, 2020.
+Added: Amendment to Research Subaward Agreement, entered into as of August 11, 2020, by and between Registrant and Yale University.
+Added: Separation Agreement, dated as of October 15, 2020, by and between the Registrant and William S.
+Added: Marshall, Ph.D.
+Added: Consulting Agreement, dated as of October 16, 2020, by and between the Registrant and William S.
+Added: Marshall, Ph.D.
+Added: Bonus Agreement, dated as of September 14, 2020, by and between the Registrant and Jason Leverone.
+Added: Bonus Agreement, dated as of September 27, 2020, by and between the Registrant and Diana Escolar, M.D.
+Added: 8-K/A 10/01/2020 10.5
+Added: Amended and Restated Employment Agreement, dated as of September 14, 2020, by and between the Registrant and Lee Rauch.
8-K 09/17/2020 10.3
−Removed: Employment Agreement by and between the Registrant and Lee Rauch, dated as of June 16, 2020.
+Added: Securities Purchase Agreement, dated as of October 27, 2020, by and among the Registrant and each purchaser identified on Annex A thereto.
8-K 10/28/2020 10.1
+Added: Registration Rights Agreement, dated as of October 30, 2020, by and among the Registrant and certain purchasers.
Certification of Principal Executive Officer pursuant to Rule13a-14(a) and Rule 15d-14(a) of the Securities and Exchange Act, as amended.
10 unchanged sentences
____________________
+Added: ^ Schedules have been omitted from this filing pursuant to Item 601(b)(2) of Regulation S-K.
+Added: Miragen agrees to furnish supplementally a copy of any omitted schedule to the SEC upon its request;
+Added: provided, however, that Miragen may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any schedule so furnished.
Certain portions of the exhibit, identified by the mark, “[*],” have been omitted because such portions contained information that is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.
2 unchanged sentences
** In accordance with Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Exchange Act of 1934, as amended, and otherwise are not subject to liability under these sections.
−Removed: x Field herewith.
+Added: x Filed herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MIRAGEN THERAPEUTICS, INC.
−Removed: August 5, 2020 By:
−Removed: /s/ William S.
−Removed: Marshall, Ph.D.
+Added: November 12, 2020 By:
+Added: /s/ Lee Rauch
Chief Executive Officer
(Principal Executive Officer)
−Removed: August 5, 2020 By:
+Added: November 12, 2020 By:
Chief Financial Officer
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.